Advanced Modality Research & Development Support
Support for mRNA/LNP systems, nanoparticle-based delivery, VLPs, proteins, biologics, vaccines, and other complex modalities requiring integrated delivery, formulation, and CMC thinking.
Core Capabilities
Discovery-to-Development Roadmapping
Structured planning to move promising research toward development, including technical roadmaps, key milestones, decision points, data-gap identification, and risk-based prioritization.
Early CMC and Drug Product Strategy
Guidance on formulation, stability, process design, manufacturability, scalability, and control strategy considerations before development risks become costly.
Technology Assessment and Development Readiness
Independent review of platforms, product concepts, data packages, and development plans to identify strengths, risks, data gaps, and practical next steps supporting investment, partnering, funding, or internal decision-making.
Recent News & Insights*
Contact
For consulting inquiries, collaborations, or discussions related to drug product development, delivery platforms, or early CMC strategy, please reach out directly:
* This information is provided for general informational purposes only and does not constitute professional or regulatory advice. While efforts are made to ensure accuracy, SterPath does not guarantee completeness or assume responsibility for any errors or omissions.
Design based on Editorial by HTML5 UP --- Images sourced from Unsplash